DEA Quadruples Psilocybin Manufacturing for Research in Final 2021 Production Quotas
Drug Enforcement Agency also hugely boosts MDMA and DMT quotas “in response to the nationwide public interest in hallucinogenic controlled substances research.”
Author: Emily Jarvie
Psychedelic Business Spotlight: November 12
This week in psychedelic business news: two of the biggest players in the industry unveil big data; Numinus Wellness helps MAPS expand MDMA study; and Ketamine One announces IPO intention.
Canada Reaches Psychedelic Milestone with First Legal Group Psilocybin Therapy Session
And the results, according to the participants, were nothing short of “profound.”
MAPS Expands MDMA-Assisted Therapy for PTSD Trial Into Canada
Rick Doblin’s organization partners with Numinus Wellness to manage the Canadian sites where therapists will be administering the psychedelic therapy.
Largest Psilocybin Therapy Trial Ever Conducted Shows Depressive Symptoms Rapidly Reduce
“A single dose of psilocybin generated a rapid response that lasted up to 12 weeks,” explains principal investigator Dr. David J. Hellerstein, who was evaluating Compass Pathways’ novel drug formulation COMP360.
Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the ‘Superior Molecule’
Pre-clinical studies demonstrated multiple advantages, including less patient variability, faster onset of action, shorter duration of effect, and improved brain penetration.
Psychedelic Business Spotlight: November 5
This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
FDA Approves First Clinical Trial Using Naturally Sourced Psychedelics
This trial, using Filament Health’s botanical drug candidates, is the first to assess the direct administration of psilocin.
Detroit Voters Decriminalize Plant Psychedelics
As the decriminalization movement sweeps through Michigan, Detroit becomes the largest city in the state to decriminalize entheogenic plants.
Lil Nas X Says Psychedelics Helped Him ‘Open Up’ to Write Debut Album ‘Montero’
Pop star says in new interview that tripping on psilocybin enabled him, for the first time, to “write actual stories about my life and put it into my music.”
End of content
End of content